Dr. Matthew A. Sparks, eAJKD Advisory Board member

Matthew A. Sparks, MD, is a physician-scientist in the Division of Nephrology at Duke University Medical Center and the Durham VA Medical Center in Durham, NC. He completed his residency in internal medicine at the University of Arkansas for Medical Sciences in Little Rock, AR where he also served as chief resident. He then completed his nephrology fellowship training at Duke with additional training in hypertension research. His lab is interested in understanding how both the renin angiotensin and prostanoid systems regulate blood pressure by altering blood flow to the kidney. The lab utilizes a combination of physiologic and molecular techniques in genetically modified mice to probe questions about how changes in the micro circulation of the kidney alter sodium excretion. The overarching goal of this research is to identify novel mechanisms to target drug therapy for patients with hypertension. His research is funded by a career development award from the Department of Veterans Affairs Office of Research and Development (BXIK2BX002240) and a Scientist Development Grant from the American Heart Association. Click here to view his publications in pubmed. He is also interested in enhancing medical education in nephrology. He has served on the editorial board of ASN Kidney News and as past deputy editor of Renal Fellow Network. His publications include using social media in nephrology education and he is interested in finding novel ways to share and understand medical research and information. He is a fellow of the American Society of Nephrology (ASN), the National Kidney Foundation (NKF) and a member of the ASN education committee.

miR-186 in FSGS: Entering a New Era in Biomarkers

The hunt for novel biomarkers for the diagnosis and monitoring of kidney diseases has intensified over the last decade, and several important advances are beginning to make their way into clinical medicine. Most notable is anti-PLA2R antibody testing for the diagnosis and monitoring of membranous nephropathy. In fact, a clinical test for anti-PLA2R antibodies was […]

The Name Game: An Improved Search Algorithm for Finding CKD Literature


What is in a name? The field of nephrology has grown accustomed to name changes. It seems we are never satisfied with only one name. Is it the Renal Division or the Division of Nephrology? How about Renal Week, or what we now call Kidney Week? What used to be acute renal failure is now […]

Page the Renal fellow, please!


Much has been made about the decline of physicians entering a career in nephrology over the last decade. To be fair, this is a predicament with multiple factors at play. One such factor is work-life balance. It has recently been shown that ~50% of nephrology fellows show some degree of dissatisfaction in their career choice secondary […]

Test Your Knowledge: GFR Estimation


Understanding the principles of glomerular filtration rate (GFR) estimation is critical to clinical practice and research. A recent article by Levey et al in AJKD discusses the physiology of glomerular filtration, and the application of GFR estimation for clinical care and public health. The following questions will test your knowledge on this important topic: 1. […]

NephJC: A Controlled Trial of Renal Denervation


The NephJC offering this week is the SYMPLICITY HTN-3 renal denervation trial reported in the NEJM. SYMPLICITY HTN-3 was the definitive randomized placebo controlled (sham) trial that was supposed to get renal denervation for resistant hypertension FDA approval and open up the money gates for Medtronic the manufacturer of the device. The results represented the most […]

SCM14: Kidney Transplant Outcomes in IgA Nephopathy

SCM14 logo

Dr. Aditya Kadiyala (AK), Nephrology Fellow at Hofstra North Shore-LIJ School of Medicine,  discusses his abstract for the National Kidney Foundation’s 2014 Spring Clinical Meetings (SCM14), Outcomes After Kidney Transplantation in Patients with IGA Nephropathy: An Analysis of the UNOS/OPTN Database, with Dr. Matt Sparks (eAJKD), eAJKD Advisory Board member. (Note: Dr. Kenar Jhaveri, eAJKD […]

SCM14: Are Hip Fractures Increasing in Patients on RRT?

SCM14 logo

Drs. Anna Mathew and Shailaja Chidella (AM&SC), from Hofstra North Shore-LIJ School of Medicine, discuss their abstract for the National Kidney Foundation’s 2014 Spring Clinical Meetings (SCM14), Increasing Hip Fracture Rates in Patients Receiving Hemodialysis and Peritoneal Dialysis, with Dr. Matt Sparks (eAJKD), eAJKD Advisory Board member. (Note: Dr. Kenar Jhaveri, eAJKD Editor, is one […]

NephMadness 2014: The Popular Vote Round 4, 5, and 6


See the final standings! | NephMadness.com for backstory | #NephMadness on Twitter Round Four, Forming the Final Four. This is the most important round, because it determined the champion of each individual region. Toxin versus Hypertension 2 JNC8: 44 1 ACEi ARBs combo: 41 3 Systolic BP: 34 5 Chlorthalidone: 34 1 Aristolochic Acid: 21 7 KDIGO BP in CKD: 13 7 Osmolar Gap: 12 8 Hemoperfusion: 10 8 Renal Artery Tx: 9 6 […]

NephMadness 2014 • Thanks

Nephrology Madness 2014

See the final standings! | NephMadness.com for backstory | #NephMadness on Twitter As you might imagine, pulling off NephMadness was a huge undertaking. So many people were involved in creating this educational initiative. The NephMadness team would like to thank the multiple people who made this possible. We have been working on this project since we left ASN […]

NephMadness 2014 • Winners

Nephrology Madness 2014

See the final standings! | Go to nephmadness.com for back story | #NephMadness on Twitter   The NephMadness 2014 Champion has been crowned and now it’s time to declare the prize winners of the tournament! Of course, as we’ve been saying all along, it’s not about winners or losers, but about learning nephrology. The grand prize winner with the […]


Get every new post delivered to your Inbox.

Join 4,574 other followers